Todd JA: Etiology of type 1 diabetes. Immunity. 2010, 32: 457-467. 10.1016/j.immuni.2010.04.001.
Article
CAS
PubMed
Google Scholar
Diabetes Control and Complication Trial Study Group (DCCT): The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes-mellitus. N Engl J Med. 1993, 329: 977-986.
Article
Google Scholar
Cryer PE: The barrier of hypoglycemia in diabetes. Diabetes. 2008, 57: 3169-3176. 10.2337/db08-1084.
Article
CAS
PubMed
PubMed Central
Google Scholar
Nixon R, Pickup JC: Fear of hypoglycemia in type 1 diabetes managed by continuous subcutaneous insulin infusion: is it associated with poor glycemic control?. Diabetes Technol Ther. 2011, 13: 93-98. 10.1089/dia.2010.0192.
Article
CAS
PubMed
Google Scholar
Wild D, Von Maltzahn R, Brohan E, Christensen T, Clauson P, Gonder-Frederick L: A critical review of the literature on fear of hypoglycemia in diabetes: Implications for diabetes management and patient education. Patient Educ Couns. 2007, 68: 10-15. 10.1016/j.pec.2007.05.003.
Article
PubMed
Google Scholar
Klonoff DC: Continuous glucose monitoring: roadmap for 21st century diabetes therapy. Diabetes Care. 2005, 28: 1231-1239. 10.2337/diacare.28.5.1231.
Article
PubMed
Google Scholar
Bergenstal RM, Tamborlane WV, Ahmann A, Buse JB, Dailey G, Davis SN, Joyce C, Peoples T, Perkins BA, Welsh JB, Willi SM, Wood MA: Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes. N Engl J Med. 2010, 363: 311-320. 10.1056/NEJMoa1002853.
Article
CAS
PubMed
Google Scholar
Tamborlane WV, Beck RW, Bode BW, Buckingham B, Chase HP, Clemons R, Fiallo-Scharer R, Fox LA, Gilliam LK, Hirsch IB, Huang ES, Kollman C, Kowalski AJ, Laffel L, Lawrence JM, Lee J, Mauras N, O'Grady M, Ruedy KJ, Tansey M, Tsalikian E, Weinzimer S, Wilson DM, Wolpert H, Wysocki T, Xing D: Continuous glucose monitoring and intensive treatment of type 1 diabetes. N Engl J Med. 2008, 359: 1464-1476.
Article
PubMed
Google Scholar
Hovorka R: Continuous glucose monitoring and closed-loop systems. Diabet Med. 2006, 23: 1-12.
Article
CAS
PubMed
Google Scholar
Steil GM, Rebrin K: Closed-loop insulin delivery - what lies between where we are and where we are going?. Expert Opin Drug Deliv. 2005, 2: 353-362. 10.1517/17425247.2.2.353.
Article
CAS
PubMed
Google Scholar
Renard E, Costalat G, Chevassus H, Bringer J: Artificial beta-cell: clinical experience toward an implantable closed-loop insulin delivery system. Diabetes Metab. 2006, 32: 497-502. 10.1016/S1262-3636(06)72802-6.
Article
CAS
PubMed
Google Scholar
Hovorka R: Closed-loop insulin delivery: from bench to clinical practice. Nat Rev Endocrinol. 2011, 7: 385-395. 10.1038/nrendo.2011.32.
Article
CAS
PubMed
Google Scholar
Bequette BW: A critical assessment of algorithms and challenges in the development of a closed-loop artificial pancreas. Diabetes Technol Ther. 2005, 7: 28-47. 10.1089/dia.2005.7.28.
Article
CAS
PubMed
Google Scholar
Marchetti G, Barolo M, Jovanovic L, Zisser H, Seborg DE: An improved PID switching control strategy for type 1 diabetes. IEEE Trans Biomed Eng. 2008, 55: 857-865.
Article
PubMed
Google Scholar
Steil GM, Panteleon AE, Rebrin K: Closed-loop insulin delivery-the path to physiological glucose control. Adv Drug Deliv Rev. 2004, 56: 125-144. 10.1016/j.addr.2003.08.011.
Article
CAS
PubMed
Google Scholar
Hovorka R, Canonico V, Chassin LJ, Haueter U, Massi-Benedetti M, Orsini FM, Pieber TR, Schaller HC, Schaupp L, Vering T, Wilinska ME: Nonlinear model predictive control of glucose concentration in subjects with type 1 diabetes. Physiol Meas. 2004, 25: 905-920. 10.1088/0967-3334/25/4/010.
Article
PubMed
Google Scholar
Magni L, Raimondo DM, Bossi L, Man CD, De NG, Kovatchev B, Cobelli C: Model predictive control of type 1 diabetes: an in silico trial. J Diabetes Sci Technol. 2007, 1: 804-812.
Article
PubMed
PubMed Central
Google Scholar
Parker RS, Doyle FJ, Peppas NA: A model-based algorithm for blood glucose control in type I diabetic patients. IEEE Trans Biomed Eng. 1999, 46: 148-157. 10.1109/10.740877.
Article
CAS
PubMed
Google Scholar
El-Khatib FH, Jiang J, Damiano ER: Adaptive closed-loop control provides blood-glucose regulation using dual subcutaneous insulin and glucagon infusion in diabetic swine. J Diabetes Sci Technol. 2007, 1: 181-192.
Article
PubMed
PubMed Central
Google Scholar
Lee H, Buckingham BA, Wilson DM, Bequette BW: A closed-loop artificial pancreas using model predictive control and a sliding meal size estimator. J Diabetes Sci Technol. 2009, 3: 1082-1090.
Article
PubMed
PubMed Central
Google Scholar
Wang Y, Dassau E, Doyle FJ: Closed-loop control of artificial pancreatic Beta -cell in type 1 diabetes mellitus using model predictive iterative learning control. IEEE Trans Biomed Eng. 2010, 57: 211-219.
Article
PubMed
Google Scholar
Grosman B, Dassau E, Zisser HC, Jovanovic L, Doyle FJ: Zone model predictive control: a strategy to minimize hyper- and hypoglycemic events. J Diabetes Sci Technol. 2010, 4: 961-975.
Article
PubMed
PubMed Central
Google Scholar
Kovatchev B, Patek S, Dassau E, Doyle FJ, Magni L, De NG, Cobelli C: Control to range for diabetes: functionality and modular architecture. J Diabetes Sci Technol. 2009, 3: 1058-1065.
Article
PubMed
PubMed Central
Google Scholar
Hovorka R, Allen JM, Elleri D, Chassin LJ, Harris J, Xing D, Kollman C, Hovorka T, Larsen AM, Nodale M, De PA, Wilinska ME, Acerini CL, Dunger DB: Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial. Lancet. 2010, 375: 743-751. 10.1016/S0140-6736(09)61998-X.
Article
CAS
PubMed
Google Scholar
Atlas E, Nimri R, Miller S, Grunberg EA, Phillip M: MD-logic artificial pancreas system: a pilot study in adults with type 1 diabetes. Diabetes Care. 2010, 33: 1072-1076. 10.2337/dc09-1830.
Article
PubMed
PubMed Central
Google Scholar
Steil GM, Palerm CC, Kurtz N, Voskanyan G, Roy A, Paz S, Kandeel FR: The effect of insulin feedback on closed loop glucose control. J Clin Endocrinol Metab. 2011, 96: 1402-1408. 10.1210/jc.2010-2578.
Article
CAS
PubMed
PubMed Central
Google Scholar
Kowalski AJ: Can we really close the loop and how soon? Accelerating the availability of an artificial pancreas: a roadmap to better diabetes outcomes. Diabetes Technol Ther. 2009, 11: S113-S119. 10.1089/dia.2008.0021.
Article
CAS
PubMed
Google Scholar
Buckingham B, Wilson DM, Lecher T, Hanas R, Kaiserman K, Cameron F: Duration of nocturnal hypoglycemia before seizures. Diabetes Care. 2008, 31: 2110-2112. 10.2337/dc08-0863.
Article
PubMed
PubMed Central
Google Scholar
Cryer PE: Glucose counterregulation in normal and diabetic man. Clin Physiol. 1985, 5 (Suppl 5): 61-65.
PubMed
Google Scholar
Cryer PE: Mechanisms of hypoglycemia-associated autonomic failure and its component syndromes in diabetes. Diabetes. 2005, 54: 3592-3601. 10.2337/diabetes.54.12.3592.
Article
CAS
PubMed
Google Scholar
Simonson DC, Tamborlane WV, DeFronzo RA, Sherwin RS: Intensive insulin therapy reduces counterregulatory hormone responses to hypoglycemia in patients with type I diabetes. Ann. Intern Med. 1985, 103: 184-190.
CAS
Google Scholar
Jones TW, Porter P, Sherwin RS, Davis EA, O'Leary P, Frazer F, Byrne G, Stick S, Tamborlane WV: Decreased epinephrine responses to hypoglycemia during sleep. N Engl J Med. 1998, 338: 1657-1662. 10.1056/NEJM199806043382303.
Article
CAS
PubMed
Google Scholar
Pickup JC: Semi-closed-loop insulin delivery systems: early experience with low-glucose insulin suspend pumps. Diabetes Technol Ther. 2011, 13: 695-698. 10.1089/dia.2011.0103.
Article
PubMed
Google Scholar
Attia N, Jones TW, Holcombe J, Tamborlane WV: Comparison of human regular and lispro insulins after interruption of continuous subcutaneous insulin infusion and in the treatment of acutely decompensated IDDM. Diabetes Care. 1998, 21: 817-821. 10.2337/diacare.21.5.817.
Article
CAS
PubMed
Google Scholar
Guerci B, Meyer L, Salle A, Charrie A, Dousset B, Ziegler O, Drouin P: Comparison of metabolic deterioration between insulin analog and regular insulin after a 5-hour interruption of a continuous subcutaneous insulin infusion in type 1 diabetic patients. J Clin Endocrinol Metab. 1999, 84: 2673-2678. 10.1210/jc.84.8.2673.
CAS
PubMed
Google Scholar
Krzentowski G, Scheen A, Castillo M, Luyckx AS, Lefebvre PJ: A 6-hour nocturnal interruption of a continuous subcutaneous insulin infusion. Metabolic and hormonal consequences and scheme for a prompt return to adequate control. Diabetologia. 1983, 24: 314-318.
Article
CAS
PubMed
Google Scholar
Pickup JC, Viberti GC, Bilous RW, Keen H, Alberti KGMM, Home PD, Binder C: Safety of continuous subcutaneous insulin infusion. Metabolic deterioration and glycemic auto-regulation after deliberate cessation of infusion. Diabetologia. 1982, 22: 175-179.
Article
CAS
PubMed
Google Scholar
Scheen A, Castillo M, Jandrain B, Krzentowski G, Henrivaux P, Luyckx A, Lefebvre P: A 2-hour nocturnal interruption of continuous subcutaneous insulin infusion induces a delayed and sustained metabolic deterioration in C-peptide negative type-1 (insulin-dependent) diabetic patients. Diabetologia. 1983, 25: 192-192.
Google Scholar
Buckingham B, Cobry E, Clinton P, Gage V, Caswell K, Kunselman E, Cameron F, Chase HP: Preventing hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Technol Ther. 2009, 11: 93-97. 10.1089/dia.2008.0032.
Article
CAS
PubMed
PubMed Central
Google Scholar
Buckingham B, Chase HP, Dassau E, Cobry E, Clinton P, Gage V, Caswell K, Wilkinson J, Cameron F, Lee H, Bequette BW, Doyle FJ: Prevention of nocturnal hypoglycemia using predictive alarm algorithms and insulin pump suspension. Diabetes Care. 2010, 33: 1013-1017. 10.2337/dc09-2303.
Article
PubMed
PubMed Central
Google Scholar
Diabetes Control and Complication Trial Study Group (DCCT): Epidemiology of severe hypoglycemia in the diabetes control and complications trial. Am J Med. 1991, 90: 450-459.
Article
Google Scholar
Elleri D, Acerini CL, Allen JM, Hayes J, Pesterfield C, Wilinska ME, Dunger DB, Hovorka R: Parental attitudes towards overnight closed-loop glucose control in children with type 1 diabetes. Diabetes Technol Ther. 2010, 12: 35-39. 10.1089/dia.2009.0084.
Article
PubMed
Google Scholar
Hovorka R, Kumareswaran K, Harris J, Allen JM, Elleri D, Xing D, Kollman C, Nodale M, Murphy HR, Dunger DB, Amiel SA, Heller SR, Wilinska ME, Evans ML: Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies. BMJ. 2011, 342: d1855-10.1136/bmj.d1855.
Article
PubMed
PubMed Central
Google Scholar
Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, Temple R, Dunger DB, Haidar A, Nodale M, Wilinska ME, Hovorka R: Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes. Diabetes Care. 2011, 34: 406-411. 10.2337/dc10-1796.
Article
CAS
PubMed
PubMed Central
Google Scholar
Weinzimer SA, Steil GM, Swan KL, Dziura J, Kurtz N, Tamborlane WV: Fully automated closed-loop insulin delivery versus semi-automated hybrid control in pediatric patients with type 1 diabetes using an artificial pancreas. Diabetes Care. 2008, 31: 934-939. 10.2337/dc07-1967.
Article
PubMed
Google Scholar
Murphy HR, Kumareswaran K, Elleri D, Allen JM, Caldwell K, Biagioni M, Simmons D, Dunger DB, Nodale M, Wilinska ME, Amiel SA, Hovorka R: Safety and efficacy of 24 h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series. Diabetes Care. 2011.
Google Scholar
Castle JR, Engle JM, El YJ, Massoud RG, Yuen KC, Kagan R, Ward WK: Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes. Diabetes Care. 2010, 33: 1282-1287. 10.2337/dc09-2254.
Article
CAS
PubMed
PubMed Central
Google Scholar
El-Khatib FH, Russell SJ, Nathan DM, Sutherlin RG, Damiano ER: A bihormonal closed-loop artificial pancreas for type 1 diabetes. Sci Transl Med. 2010, 2: 27ra27-10.1126/scitranslmed.3000619.
Article
PubMed
PubMed Central
Google Scholar
Wilinska ME, Chassin LJ, Acerini CL, Allen JM, Dunger DB, Hovorka R: Simulation environment to evaluate closed-loop insulin delivery systems in type 1 diabetes. J Diabetes Sci Technol. 2010, 4: 132-144.
Article
PubMed
PubMed Central
Google Scholar
Kovatchev BP, Breton M, Man CD, Cobelli C: In silico preclinical trials: a proof of concept in closed-loop control of type 1 diabetes. J Diabetes Sci Technol. 2009, 3: 44-55.
Article
PubMed
PubMed Central
Google Scholar
Wilinska ME, Budiman ES, Taub MB, Elleri D, Allen JM, Acerini CL, Dunger DB, Hovorka R: Overnight closed-loop insulin delivery with model predictive control: assessment of hypoglycemia and hyperglycemia risk using simulation studies. J Diabetes Sci Technol. 2009, 3: 1109-1120.
Article
PubMed
PubMed Central
Google Scholar
Kanderian SS, Weinzimer S, Voskanyan G, Steil GM: Identification of intraday metabolic profiles during closed-loop glucose control in individuals with type 1 diabetes. J Diabetes Sci Technol. 2009, 3: 1047-1057.
Article
PubMed
PubMed Central
Google Scholar
Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group: Satisfaction with continuous glucose monitoring in adults and youths with Type 1 diabetes. Diabet Med. 2011, 28 (9): 1118-1122. 10.1111/j.1464-5491.2011.03368.x.
Article
Google Scholar
Elleri D, Harris J, Kumareswaran K, Allen JM, Haidar A, Nodale M, Swamy A, Wilinska ME, Weston J, Acerini CL, Jackson N, Umpleby AM, Evans ML, Dunger DB, Hovorka R: Glucose appearance of large slowly-absorbed evening meal containing complex carbohydrates (CHO) in type 1 diabetes (T1D). Diabetologia. 2010, 53 (Suppl 1): S 272.
Google Scholar
Weinzimer SA, Sherr JL, Cengiz E, Kim G, Carria L, Tamborlane WV: Effect of adjuvant injected pramlintide on closed-loop automated insulin delivery. Diabetes. 2011, 60 (Supll 1): A 253.
Google Scholar
Hompesch M, Muchmore DB, Morrow L, Vaughn DE: Accelerated insulin pharmacokinetics and improved postprandial glycemic control in patients with type 1 diabetes after coadministration of prandial insulins with hyaluronidase. Diabetes Care. 2011, 34: 666-668. 10.2337/dc10-1892.
Article
CAS
PubMed
PubMed Central
Google Scholar
Steiner S, Hompesch M, Pohl R, Simms P, Flacke F, Mohr T, Pfutzner A, Heinemann L: A novel insulin formulation with a more rapid onset of action. Diabetologia. 2008, 51: 1602-1606. 10.1007/s00125-008-1095-8.
Article
CAS
PubMed
PubMed Central
Google Scholar
Renard E, Place J, Cantwell M, Chevassus H, Palerm CC: Closed-loop insulin delivery using a subcutaneous glucose sensor and intraperitoneal insulin delivery: feasibility study testing a new model for the artificial pancreas. Diabetes Care. 2010, 33: 121-127. 10.2337/dc09-1080.
Article
CAS
PubMed
Google Scholar
Liebl A, Hoogma R, Renard E, Geelhoed-Duijvestijn PH, Klein E, Diglas J, Kessler L, Melki V, Diem P, Brun JM, Schaepelynck-Belicar P, Frei T: A reduction in severe hypoglycaemia in type 1 diabetes in a randomized crossover study of continuous intraperitoneal compared with subcutaneous insulin infusion. Diabetes Obes Metab. 2009, 11: 1001-1008. 10.1111/j.1463-1326.2009.01059.x.
Article
CAS
PubMed
Google Scholar
Kumareswaran K, Elleri D, Allen JM, Harris J, Xing D, Kollman C, Nodale M, Murphy HR, Amiel SA, Heller SR, Wilinska ME, Acerini CL, Evans ML, Dunger DB, Hovorka R: Meta-analysis of overnight closed-loop randomised studies in children and adults with type 1 diabetes: the Cambridge cohort. J Diabetes Sci Technol. 2011.
Google Scholar
Choudhary P, Shin J, Wang Y, Evans ML, Hammond PJ, Kerr D, Shaw JA, Pickup JC, Amiel SA: Insulin pump therapy with automated insulin suspension in response to hypoglycemia: reduction in nocturnal hypoglycemia in those at greatest risk. Diabetes Care. 2011, 34: 2023-2025. 10.2337/dc10-2411.
Article
CAS
PubMed
PubMed Central
Google Scholar
Danne T, Kordonouri O, Holder M, Haberland H, Golembowski S, Remus K, Blasig S, Wadien T, Zierow S, Hartmann R, Thomas A: Prevention of hypoglycemia by using low glucose suspend function in sensor-augmented pump therapy. Diabetes Technol Ther. 2011, 13: 1-6. 10.1089/dia.2010.0116.
Article
Google Scholar
Kovatchev B, Cobelli C, Renard E, Anderson S, Breton M, Patek S, Clarke W, Bruttomesso D, Maran A, Costa S, Avogaro A, Dalla MC, Facchinetti A, Magni L, De NG, Place J, Farret A: Multinational study of subcutaneous model-predictive closed-loop control in type 1 diabetes mellitus: summary of the results. J Diabetes Sci Technol. 2010, 4: 1374-1381.
Article
PubMed
PubMed Central
Google Scholar
Steil GM, Rebrin K, Darwin C, Hariri F, Saad MF: Feasibility of automating insulin delivery for the treatment of type 1 diabetes. Diabetes. 2006, 55: 3344-3350. 10.2337/db06-0419.
Article
CAS
PubMed
Google Scholar